00173-0896
Blenrep
Belantamab
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
BELANTAMAB MAFODOTIN
50.0
mg/mL
00173-0896-01
1 VIAL in 1 CARTON (0173-0896-01) > 2 mL in 1 VIAL
Aug. 5, 2020
Immunotherapy
Drug Antibody Conjugate
BCMA
 
In Use